NCT05750446View on ClinicalTrials.gov

Effect of Riocigaut on Migraine Attack Induction in People With Migraine

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

February 1, 2024

Study Completion Date

February 1, 2024

Conditions
Migraine Without Aura
Interventions
DRUG

Riociguat (BAY 63-2521)

A selective stimulator of soluble guanylate cyclase (sGC)

OTHER

Placebo

Placebo

Trial Locations (1)

2600

Danish Headache Center, Copenhagen

All Listed Sponsors
lead

Danish Headache Center

OTHER

NCT05750446 - Effect of Riocigaut on Migraine Attack Induction in People With Migraine | Biotech Hunter | Biotech Hunter